Literature DB >> 17712623

Overexpressed alpha-synuclein regulated the nuclear factor-kappaB signal pathway.

Yuhe Yuan1, Jin Jin, Bo Yang, Wei Zhang, Jinfeng Hu, Yun Zhang, Nai-Hong Chen.   

Abstract

Alpha-synuclein is a presynaptic protein which is implicated in some neurodegenerative disorders including Parkinson's disease, dementia with Lewy bodies, multiple systems atrophy, and Hallervorden-Spatz disease, and its overexpression contributes to the loss of dopaminergic neurons. Although the role of alpha-synuclein in these paradigms has been widely documented, its exact function is still elusive. And the dysfunction of the transcription factor nuclear factor (NF-kappaB) also exists in many neurodegenerative diseases. In this reason the purpose of this study was to investigate the molecular mechanism of alpha-synuclein's toxicity and its association with NF-kappaB by MTT assay, Western blot method, and luciferase assay. Results showed that overexpressed alpha-synuclein and 1-methyl-4-phenylpyridinium (MPP(+)) suppressed the SH-SY5Y cell viability and attenuate NF-kappaB-mediated luciferase expression significantly. Moreover, the impairment function was enhanced with the increase of alpha-synuclein protein level. We also found that overexpressed alpha-synuclein localized both in the cytoplasms and nuclei, down-regulated the anti-apoptotic Bcl-2 expression and up-regulated the pro-apoptotic glycogen synthase kinase 3beta (GSK3beta) protein level. In conclusion, all these findings mentioned above suggested that alpha-synuclein shared some toxic functional homology with neurotoxin MPP(+), and the proapoptotic effects of alpha-synuclein might be mediated at least in part by the impairment of NF-kappaB signaling pathway which involves GSK3beta.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17712623     DOI: 10.1007/s10571-007-9185-6

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  48 in total

1.  Nuclear localization of alpha-synuclein and its interaction with histones.

Authors:  John Goers; Amy B Manning-Bog; Alison L McCormack; Ian S Millett; Sebastian Doniach; Donato A Di Monte; Vladimir N Uversky; Anthony L Fink
Journal:  Biochemistry       Date:  2003-07-22       Impact factor: 3.162

Review 2.  Animal models of parkinsonism using selective neurotoxins: clinical and basic implications.

Authors:  M J Zigmond; E M Stricker
Journal:  Int Rev Neurobiol       Date:  1989       Impact factor: 3.230

3.  Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal.

Authors:  L Maroteaux; J T Campanelli; R H Scheller
Journal:  J Neurosci       Date:  1988-08       Impact factor: 6.167

4.  alpha-Synuclein shares physical and functional homology with 14-3-3 proteins.

Authors:  N Ostrerova; L Petrucelli; M Farrer; N Mehta; P Choi; J Hardy; B Wolozin
Journal:  J Neurosci       Date:  1999-07-15       Impact factor: 6.167

5.  Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity.

Authors:  Eirene Kontopoulos; Jeffrey D Parvin; Mel B Feany
Journal:  Hum Mol Genet       Date:  2006-09-07       Impact factor: 6.150

6.  Role of glycogen synthase kinase-3beta in neuronal apoptosis induced by trophic withdrawal.

Authors:  M Hetman; J E Cavanaugh; D Kimelman; Z Xia
Journal:  J Neurosci       Date:  2000-04-01       Impact factor: 6.167

7.  Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease.

Authors:  Jin Xu; Shyan-Yuan Kao; Frank J S Lee; Weihong Song; Lee-Way Jin; Bruce A Yankner
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

8.  Subcellular localisation of recombinant alpha- and gamma-synuclein.

Authors:  Christian G Specht; Cezar M Tigaret; Georg F Rast; Agnes Thalhammer; York Rudhard; Ralf Schoepfer
Journal:  Mol Cell Neurosci       Date:  2005-02       Impact factor: 4.314

9.  Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein.

Authors:  S Arawaka; Y Saito; S Murayama; H Mori
Journal:  Neurology       Date:  1998-09       Impact factor: 9.910

10.  Methylpyridinium (MPP(+))- and nerve growth factor-induced changes in pro- and anti-apoptotic signaling pathways in SH-SY5Y neuroblastoma cells.

Authors:  Erik M Halvorsen; Jameel Dennis; Paula Keeney; Thomas W Sturgill; Jeremy B Tuttle; James B Bennett
Journal:  Brain Res       Date:  2002-10-11       Impact factor: 3.252

View more
  18 in total

1.  Identification of ciliary neurotrophic factor receptor alpha as a mediator of neurotoxicity induced by alpha-synuclein.

Authors:  Jun Liu; Min Shi; Zhen Hong; JianPeng Zhang; Joshua Bradner; Thomas Quinn; Richard P Beyer; Patrick L Mcgeer; ShengDi Chen; Jing Zhang
Journal:  Proteomics       Date:  2010-06       Impact factor: 3.984

2.  Reduced expression of peroxisome-proliferator activated receptor gamma coactivator-1alpha enhances alpha-synuclein oligomerization and down regulates AKT/GSK3beta signaling pathway in human neuronal cells that inducibly express alpha-synuclein.

Authors:  Abdul Shukkur Ebrahim; Li-Wen Ko; Shu-Hui Yen
Journal:  Neurosci Lett       Date:  2010-02-21       Impact factor: 3.046

3.  Distinct mechanisms of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine resistance revealed by transcriptome mapping in mouse striatum.

Authors:  R Pattarini; Y Rong; C Qu; J I Morgan
Journal:  Neuroscience       Date:  2008-07-08       Impact factor: 3.590

4.  MicroRNA-7 protects against 1-methyl-4-phenylpyridinium-induced cell death by targeting RelA.

Authors:  Doo Chul Choi; Yoon-Jee Chae; Savan Kabaria; Amrita Datta Chaudhuri; Mohit Raja Jain; Hong Li; M Maral Mouradian; Eunsung Junn
Journal:  J Neurosci       Date:  2014-09-17       Impact factor: 6.167

5.  Overexpression of alpha-synuclein down-regulates BDNF expression.

Authors:  Yuhe Yuan; Jiandong Sun; Ming Zhao; Jinfeng Hu; Xiaoliang Wang; Guohua Du; Nai-Hong Chen
Journal:  Cell Mol Neurobiol       Date:  2010-04-20       Impact factor: 5.046

Review 6.  The role of NURR1 in metabolic abnormalities of Parkinson's disease.

Authors:  Murad Al-Nusaif; Yuting Yang; Song Li; Cheng Cheng; Weidong Le
Journal:  Mol Neurodegener       Date:  2022-06-27       Impact factor: 18.879

7.  Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies.

Authors:  David J Koss; Daniel Erskine; Andrew Porter; Pawel Palmoski; Hariharan Menon; Olivia G J Todd; Marta Leite; Johannes Attems; Tiago F Outeiro
Journal:  Acta Neuropathol Commun       Date:  2022-07-06       Impact factor: 7.578

8.  Unregulated mitochondrial GSK3beta activity results in NADH: ubiquinone oxidoreductase deficiency.

Authors:  Taj D King; Buffie Clodfelder-Miller; Keri A Barksdale; Gautam N Bijur
Journal:  Neurotox Res       Date:  2008-12       Impact factor: 3.911

9.  Prodegenerative IκBα expression in oligodendroglial α-synuclein models of multiple system atrophy.

Authors:  Christine L Kragh; Amanda M Gysbers; Edward Rockenstein; Karen Murphy; Glenda M Halliday; Eliezer Masliah; Poul Henning Jensen
Journal:  Neurobiol Dis       Date:  2013-12-17       Impact factor: 5.996

10.  Overexpression of human E46K mutant α-synuclein impairs macroautophagy via inactivation of JNK1-Bcl-2 pathway.

Authors:  Jia-Qing Yan; Yu-He Yuan; Yan-Na Gao; Ju-Yang Huang; Kai-Li Ma; Yan Gao; Wan-Qing Zhang; Xiao-Feng Guo; Nai-Hong Chen
Journal:  Mol Neurobiol       Date:  2014-05-16       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.